COMAI, GIORGIA
 Distribuzione geografica
Continente #
AS - Asia 14.004
NA - Nord America 11.005
EU - Europa 7.766
AF - Africa 760
SA - Sud America 749
Continente sconosciuto - Info sul continente non disponibili 687
OC - Oceania 32
Totale 35.003
Nazione #
US - Stati Uniti d'America 10.762
VN - Vietnam 4.409
SG - Singapore 3.409
CN - Cina 3.008
IT - Italia 2.264
GB - Regno Unito 1.322
HK - Hong Kong 1.140
DE - Germania 967
SE - Svezia 764
BR - Brasile 529
FR - Francia 518
IN - India 496
KR - Corea 378
BD - Bangladesh 338
RU - Federazione Russa 311
IE - Irlanda 287
NL - Olanda 286
UA - Ucraina 257
FI - Finlandia 227
TG - Togo 202
JP - Giappone 178
ZA - Sudafrica 145
CI - Costa d'Avorio 143
CA - Canada 134
SC - Seychelles 118
JO - Giordania 99
AR - Argentina 95
EE - Estonia 86
PH - Filippine 86
BG - Bulgaria 85
AT - Austria 74
TH - Thailandia 73
ID - Indonesia 71
NG - Nigeria 65
MX - Messico 57
IQ - Iraq 56
CH - Svizzera 50
PL - Polonia 48
TW - Taiwan 47
BE - Belgio 45
ES - Italia 44
TR - Turchia 41
EC - Ecuador 40
PK - Pakistan 34
IR - Iran 29
AU - Australia 28
SA - Arabia Saudita 28
CO - Colombia 25
EG - Egitto 19
GR - Grecia 19
CL - Cile 18
LT - Lituania 15
MA - Marocco 15
PY - Paraguay 15
UZ - Uzbekistan 14
RO - Romania 13
CZ - Repubblica Ceca 12
KE - Kenya 12
AL - Albania 10
DZ - Algeria 10
MY - Malesia 10
CR - Costa Rica 9
DK - Danimarca 9
PE - Perù 9
HR - Croazia 8
JM - Giamaica 8
RS - Serbia 8
VE - Venezuela 8
XK - ???statistics.table.value.countryCode.XK??? 8
HN - Honduras 7
KZ - Kazakistan 7
AE - Emirati Arabi Uniti 6
BA - Bosnia-Erzegovina 6
ET - Etiopia 6
NP - Nepal 6
TN - Tunisia 6
GT - Guatemala 5
IL - Israele 5
LB - Libano 5
PT - Portogallo 5
SV - El Salvador 5
UY - Uruguay 5
EU - Europa 4
HU - Ungheria 4
NI - Nicaragua 4
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
CY - Cipro 3
LK - Sri Lanka 3
MD - Moldavia 3
MK - Macedonia 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AO - Angola 2
BB - Barbados 2
BS - Bahamas 2
CG - Congo 2
DO - Repubblica Dominicana 2
Totale 34.273
Città #
Singapore 2.408
Ashburn 1.507
Ho Chi Minh City 1.134
Southend 1.053
Hong Kong 1.045
Hanoi 1.033
San Jose 756
Hefei 749
Chandler 701
Fairfield 610
Santa Clara 464
Bologna 398
Beijing 366
Seoul 333
Ann Arbor 314
Houston 313
Wilmington 313
Woodbridge 299
Dublin 283
Princeton 280
Los Angeles 270
Seattle 263
Boardman 235
Cambridge 220
Dong Ket 210
Lomé 202
Council Bluffs 197
New York 193
Lauterbourg 183
Helsinki 172
Da Nang 170
Milan 154
Tokyo 153
Jacksonville 151
Abidjan 143
Dallas 143
Haiphong 134
Buffalo 129
Munich 120
Frankfurt am Main 118
Westminster 112
Nanjing 109
Turin 104
São Paulo 100
Amman 99
Berlin 95
Rome 94
Padova 86
Sofia 83
Redondo Beach 74
Florence 72
Bremen 71
Bengaluru 69
Jinan 65
Hyderabad 64
Biên Hòa 62
Redmond 60
Hải Dương 59
Abeokuta 58
Chicago 57
The Dalles 54
Changsha 52
Phoenix 52
Guangzhou 51
Medford 49
Shenyang 47
London 46
Saint Petersburg 45
Shanghai 45
Toronto 45
Amsterdam 44
Brussels 44
Falkenstein 42
Johannesburg 42
San Francisco 42
Thái Nguyên 41
Vienna 41
Nuremberg 40
Orem 40
Jakarta 39
Des Moines 38
Modena 37
San Diego 37
Warsaw 37
Atlanta 36
Ha Long 36
Nanchang 36
Tianjin 36
Zhengzhou 35
Can Tho 34
Ninh Bình 34
Montreal 33
Redwood City 33
Bắc Ninh 32
Naples 32
Thái Bình 32
Bangkok 31
Catania 31
Dearborn 31
Quận Bình Thạnh 30
Totale 21.094
Nome #
Long Term Outcomes of Kidney Transplant: Characteristics of Recipients with 20 or More Years of Graft Survival 886
Stem Cells 371
COLONIZZAZIONE ED INFEZIONE DA KLEBSIELLA PNEUOMONIAE PRODUTTRICE DI CARBAPENEMASI (KPC) NEL PAZIENTE SOTTOPOSTO A TRAPIANTO DI RENE 334
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 333
Acute granulomatous interstitial nephritis and ulcerative colitis: A case report and literature review 297
Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial 284
Automatic Adaptive System Dialysis for Hemodialysis-Associated Hypotension and Intolerance: A Noncontrolled Multicenter Trial. 275
5-Methyltetrahydrofolate Administration Is Associated with Prolonged Survival and Reduced Inflammation in ESRD Patients 272
Correlazioni tra decoy cells urinarie, viremia BK e terapia immunosoppressiva nel trapianto di rene 270
Cardiovascular Disease in Kidney Transplant Recipients: The Prognostic Value of Inflammatory Cytokine Genotypes. 268
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 263
DNA VIRAL INFECTIONS ASSAY IN KIDNEY TRANSPLANT RECIPIENTS BY A NEW HIGH THROUGHPUT MASS SPECTROMETRY METHOD 262
Denosumab-Induced Hypocalcemia and Hyperparathyroidism in de novo Kidney Transplant Recipients 256
Hypothermic Oxygenated Perfusion in Extended Criteria Donor Kidney Transplantation-A Randomized Clinical Trial 255
Seroprevalence of a “new” bacterium, Simkania negevensis, in renal transplant recipients and in hemodialysis patients 244
An in vivo autotransplant model of renal preservation: cold storage versus machine perfusion in the prevention of ischemia/reperfusion injury. 238
Delayed Graft Function (DGF) e Trapianto Renale: studio dei principali fattori di rischio. 234
Kinetics of cytomegalovirus and Epstein-Barr virus DNA in whole blood and plasma of kidney transplant recipients: Implications on management strategies 232
Identification of expanded T-cell clones by spectratyping in nonfunctioning kidney transplants 231
Histological Evidence of Diabetic Kidney Disease Precede Clinical Diagnosis 230
Combined application of Hemodiafiltration and Profiler: short and mid-term clinical results in 16 patients. 226
Donor/recipient delta age: A possible risk for arterial stenosis in renal transplantation 222
Updated diagnosis and graft involvement for visceral leishmaniasis in kidney transplant recipients: a case report and literature review 218
Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters (TCC) thrombosis. 218
Combined liver–dual kidney transplant: Role in expanded donors 216
Methylenetetrahydrofolate reductase, MTHFR, polymorphisms and predisposition to different multifactorial disorders 215
Identification of asymptomatic Leishmania infection in patients undergoing kidney transplant using multiple tests 214
Recurrence of membranous nephropathy after kidney transplantation: A multicenter retrospective cohort study 214
Nephrological indications in combined liver kidney transplantation 212
Impact of cytokines and apoptosis molecules polymorphisms on Chronic Allograft Nephropathy 212
INDICAZIONI NEFROLOGICHE AL TRAPIANTO COMBINATO RENE-FEGATO 209
Reduction of Oxidative Damage Reflects a Better Kidney Transplantation Outcome. 209
Correlation Between Renal Cortical Stiffness and Histological Determinants by Point Shear-Wave Elastography in Patients With Kidney Transplantation 209
A case report of IgG4-related disease: an insidious path to the diagnosis through kidney, heart and brain 209
“Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy 207
INFLUENCE OF DELAYED GRAFT FUNCTION (DGF) ON RENAL TRANSPLANTATION OUTCOME 205
Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment. 205
The Relationship between Timing of Pretransplant Kidney Biopsy, Graft Loss, and Survival in Kidney Transplantation: An Italian Cohort Study 204
Risk Factors of Acute Rejection: Impact on Graft Outcomes in a Cohort of Kidney Transplant Recipients 203
Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literature 203
Prediction of Three-Year Outcome of Renal Transplantation from Optimal Donors versus Expanded Criteria Donors. 203
Urinary neutrophil gelatinase-associated lipocalin is a biomarker of delayed graft function after kidney transplantation 203
Risk factors for IgA nephropathy recurrence and impact on graft survival in a cohort of kidney transplanted patients 201
Impiego clinico del “Fegato Artificiale” MARS: effetti sulle citochine e sui fattori di crescita 201
Acute Kidney Injury and Blood Purification Techniques in Severe COVID-19 Patients 200
Increase in Serum Amylase and Resistive Index After Kidney Transplant Are Biomarkers of Delayed Graft Function 200
Is COVID-19 Coagulopathy a Thrombotic Microangiopathy? A Prospective, Observational Study 198
Genetic Factors and Risk OF Acute Rejection in Kidney Transplant 198
Identification of a serum and urine extracellular vesicle signature predicting renal outcome after kidney transplant 197
Warfarin anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters thrombosis. 196
Induction therapy with Alemtuzumab (Campath) in combined liver-kidney transplantation: University of Bologna experience. 196
An in vitro model of renal inflammation after ischemic oxidative stress injury: Nephroprotective effects of a hyaluronan ester with butyric acid on mesangial cells 196
Hierarchical clustering uncovered disease patterns and further untangled complexities in immune complex-mediated idiopathic MPGN and C3 glomerulopathy 195
A very early and acute renal impairment due to polyomavirus allograft nephropathy. 195
Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: Protocol for a single-center randomized controlled trial 195
Clinical application of artificial liver support with the Molecular Adsorbent Recirculating System (MARS): impact on cytokines and growth factors 195
Schemi di terapia immunosoppressiva e livelli ematici consigliati 193
Uremic Serum Impairs Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stromal Cells 191
Incidenza di Rigetto Acuto nel Trapianto Renale: ruolo dei fattori genetici 190
Influence of the immunogenetic KIR and HLA systems on long-term renal transplant outcome 190
Fifteen-year analysis of deceased kidney donation: A single transplant center experience in a region of northern Italy 189
Chronic allograft dysfunction: role of immunosuppressive treatment 186
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 186
Impiego combinato HFR-Profiler: risultati clinici a breve-medio termine 185
[Membranous glomerulonephritis (MGN), ongoing studies] 184
RESISTENZA AL FLUSSO E MARKERS METABOLICI COME STRUMENTI DI VALUTAZIONE D’ORGANO PER IL TRAPIANTO DI RENI MARGINALI: STUDIO PROSPETTICO ITALIANO SULLA PERFUSIONE IPOTERMICA OSSIGENATA 183
DOPPI TRAPIANTI DI RENE MONOLATERALI CON RICOSTRUZIONI VASCOLARI A BANCO IN GRFAFT CON VASI MULTIPLI E RICEVENTI SEVERAMENTE ATEROMASICI 182
Removal of free light chains in hemodialysis patients without multiple myeloma: A crossover comparison of three different dialyzers 181
Circulating extracellular particles from severe COVID-19 patients show altered profiling and innate lymphoid cell-modulating ability 180
Babesiosis in the immunocompromised population: Results from a multicentric cohort study conducted in Italy 180
Score istologico pre-trapianto e outcome del trapianto renale 180
Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function 180
Functional Abnormalities and Thyroid Nodules in Patients with End-stage Renal Disease 179
Histological findings of diabetic kidneys transplanted in non-diabetic recipients: a case series 178
Prevenzione della trombosi dei cateteri a permanenza per emodialisi: profilassi mediante anticoagulazione con warfarin 178
Polimorfismo del Vascular Endothelial Growth Factor e rischio cardiovascolare dopo trapianto renale 178
Cabozantinib-induced renal thrombotic microangiopathy 176
Treatment of Acute Antibody-Mediated Rejection 175
Corrigendum to “Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D and Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.” Kidney Int. 2020;97:1287–1296 (Kidney International (2020) 97(6) (1287–1296), (S0085253820301526), (10.1016/j.kint.2020.01.035)) 174
Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic 173
Kidney transplantation in systemic sclerosis: Advances in graft, disease, and patient outcome 172
Perfusione Continua versus Ipotermia Semplice nel Trapianto d’organo. Studio sperimentale su modello animale. 171
Hematopoietic Cell and Renal Transplantation in Plasma Cell Dyscrasia Patients. 170
Outcome of kidney function in adults on long-term home parenteral nutrition for chronic intestinal failure 170
Influence of delayed graft function (DGF) on renal transplantation outcome 168
Renal Vessel Extension With Cryopreserved Vascular Grafts: Overcoming Surgical Pitfalls in Living Donor Kidney Transplant 168
Urine-derived renal epithelial cells isolated after kidney transplant are sensitive to neutrophil gelatinase-associated lipocalin exposure during in vitro culture 167
SP714SHEAR WAVE ELASTOGRAPHY IN KIDNEY TRANSPLANTATION: NONINVASIVE ALTERNATIVE TO ALLOGRAFT BIOPSY? 167
RUOLO DELL'ISTOLOGIA NELLA DELAYED GRAFT FUNCTION 167
Double Single-Side Kidney Transplants With Bench Vascular Reconstruction: A Further Challenge Beyond the Marginality Without Future Preclusions 167
Tocilizumab-Based Treatment of Microvascular Inflammation in Kidney Transplant Recipients: A Retrospective Study 166
Urine-Derived Renal Epithelial Cells (URECs) from Transplanted Kidneys as a Promising Immunomodulatory Cell Population 166
Nephrological indications in combined liver-kidney transplantation. 166
Early use of PEPA dialyzer for light chains removal and for the recovery from myeloma cast nephropathy: A case report 166
Recurrence of iga nephropathy after kidney transplantation in adults 166
THE USE OF 3D AUGMENTED REALITY DURING ROBOT-ASSISTED LIVING DONOR NEPHRECTOMY (RALDN): A CASE REPORT TECHNICAL OVERVIEW 165
Early Light Chains Removal and Albumin Levels with a Double Filter-Based Extracorporeal Treatment for Acute Myeloma Kidney 164
Therapy strategies in the prevention of chronic allograft nephropathy 163
Post-coronarography application of continuous veno-venous hemofiltration in the prevention of contrast nephropathy in patients with complex multisystem deficiency. 163
Safety and Efficacy of Vedolizumab in Kidney Transplant Recipients With Crohn’s Disease 163
Totale 21.140
Categoria #
all - tutte 89.965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.965


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.708 183 137 175 205 246 174 73 202 119 180 549 465
2022/20233.436 305 487 166 437 253 293 108 195 631 96 303 162
2023/20241.248 79 184 63 127 79 251 67 117 38 86 85 72
2024/20255.366 250 619 504 299 663 257 329 183 112 368 491 1.291
2025/202616.348 2.262 1.536 1.089 996 1.376 767 2.296 467 2.890 1.155 741 773
2026/2027431 431 0 0 0 0 0 0 0 0 0 0 0
Totale 35.003